Session date: 
Thursday, March 15, 2018 - 7:30am to 8:30am
Location: 
Helfaer Auditorium
9200 W. Wisconsin Avenue
Milwaukee, WI 53226-0509
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
  • 1.00 NP Contact Hours
  • 1.00 PA
    PA credit.

Please login or register to take this course.
Program Description: 

Michael Rothman co-founded PeraHealth in 2005 with his brother Steven, following the preventable death of their mother, Florence. PeraHealth’s solutions are powered by the Rothman Index (RI), the most comprehensive predictive general measure of patient condition. The Rothman Index uses nursing assessments, laboratory values and vital signs to drive predictive analytics and creates a visual dashboard that helps clinicians identify early changes in patient condition – before these changes may be clinically apparent and early enough to prevent deterioration. Over the past 5 years, a growing body of robust research has demonstrated that the Rothman index prevents mortality in dramatic fashion – 30% at both Yale New Haven Medical Center and Houston Methodist hospital. F&MCW is set to go live with this functionality by the end of June.

Michael’s career began at IBM’s General Technology Division, after he earned his PhD in quantum chemistry. At IBM he worked in optimization, mathematical modeling and data analysis; work that led to a doubling of memory chip yields for mainframes. Michael also spent time at IBM’s T. J. Watson Research Labs, in the AI department, engaged in research in machine learning.

Michael is a natural interpreter of information. As a manager and executive consultant for the IBM Consulting group, his duties included translating mathematical results into effective business strategies for major banks and financial institutions.  Later, as Senior Vice President for Strategic Information at First USA Bank, Michael established a database to better determine customer preferences.

In 2000, he founded Michael Rothman & Associates to focus on data analysis and product development through consulting, patent filing and joint ventures. Projects have included developing a system generating customized discharge forms for hospitals, helping determine cash flow and profitability for a pharmaceutical company’s newly introduced drugs, and pro bono work analyzing mortality data for a guide dog school.
 

ACCME Accreditation Statement:

The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:

The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Professionals:

The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Target audience: 

The Medical Staff at Froedtert Hospital

Learning objectives: 

Discuss Rothman Index (RI)

Some key takeaways:

  • Personal loss suffered by Rothman brothers, scientists with big data analysis and statistics expertise
  • Mission: Redefine an avoidable death by predicting patient deterioration earlier
  • Solution: Rothman Index, a “Universal Patient Score” that summarizes a patient’s condition in one simple number – across all patients and all disease categories
  • A predictive warning system that alerts clinicians to subtle patient deterioration that may lead to life-threatening conditions. Based on 50+ measures (vitals, lab results, nursing notes) automatically computed from EHR data

Rothman first and foremost prevents actual mortality:  Reduction of 30% observed mortality (seen at Yale and Methodist) would reduce rate from 1.88 to 1.32%, saving 170 lives per year at FMLH.

  • Cost of $10-$15 per patient = $2250 per life saved
  • Savings of $5M-$6M per year in direct cost for sepsis
  • Additional savings from decreased ICU utilization, decreased ICU bounce-back, decreased LOS and benefit of added capacity. This would all be additional to the savings above
Faculty & credentials: 

Michael Rothman, PhD
Co-founder and Chief Science Officer, PeraHealth

CME Coordinator Contact Information

Name: 
Robin Neel
Phone number: 
+1 (414) 805-9950